Publisher's Synopsis
Explores how the heterogeneity of rheumatoid arthritis and the mechanism of drug action can be better understood by analyzing the wide range of responses to anti-rheumatic drugs. The 26 papers, from a meeting in Singapore, July 1992, consider non-steroidal anti-inflammatory drugs, trials and trial design, combination therapy, and disease modifying